Jim Cramer’s week ahead: Get ready to ‘pounce’ when the market is oversold

Jim Cramer’s week ahead: Get ready to ‘pounce’ when the market is oversold


CNBC’s Jim Cramer on Friday warned investors not to let their guard down when it comes to their portfolios and be ready to take advantage of good deals.

“Ultimately, you’re just going to feel sorry if you don’t buy anything on the big sell-offs. When the market finally gets oversold enough, though, that’s when you need to pounce,” Cramer said.

Stocks gained on Friday but finished a volatile week lower, with losses spurred by hotter-than-expected economic data, the Federal Reserve’s 75 basis point rate hike and its hawkish rhetoric on inflation.

“We’re in a wildly emotional moment that has a lot to do with how individual companies are faring and a lot to do with what Wall Street expects of them. The bottom line? Until these expectations are wrenched lower, you shouldn’t feel safe in anything,” he said.

Cramer said that he’s watching for the consumer price index release next week, along with slated speeches from Cleveland Fed president Loretta Mester that could further shake the market.

He also previewed next week’s schedule of earnings. All earnings and revenue estimates are courtesy of FactSet.

Monday: BioNTech, Take-Two Interactive

BioNTech

  • Q3 2022 earnings release at 5 a.m. ET; conference call at 8 a.m. ET
  • Projected EPS: $3.34
  • Projected revenue: $2.02 billion

Investors bullish on BioNTech should cross their fingers that the company reports that China ordered “over a billion” Covid vaccines, he said.

Take-Two Interactive

  • Q2 2023 earnings at 4:05 p.m. ET; conference call at 4:30 p.m. ET
  • Projected EPS: $1.37
  • Projected revenue: $1.55 billion

Cramer said that it’s an injustice that the company is known as a pandemic play.

Tuesday: GlobalFoundries, Disney, AMC Entertainment

GlobalFoundries

  • Q3 2022 earnings release before the bell; conference call at 8:30 a.m. ET
  • Projected EPS: 62 cents
  • Projected revenue: $2.05 billion

He said he’s interested in knowing if the chip shortage will get better before the economy takes a turn for the worse.

Disney

  • Q4 2022 earnings release at 4:05 p.m. ET; conference call at 4:30 p.m. ET
  • Projected EPS: 55 cents
  • Projected revenue: $21.28 billion

The Charitable Trust is ready to buy more shares of Disney if it comes down enough, Cramer said.

AMC Entertainment

  • Q3 2022 earnings release at 4:15 p.m. ET; conference call at 5 p.m. ET
  • Projected loss: loss of 22 cents per share
  • Projected revenue: $961 million

He said that while AMC could turn a profit in its latest quarter, he wouldn’t bet on it.

Wednesday: Wynn Resorts

  • Q3 2022 earnings release at 4 p.m. ET; conference call at 4:30 p.m. ET
  • Projected loss: loss of $1.14 per share
  • Projected revenue: $871 million

Cramer said that his Charitable Trust is sticking with the stock.

Thursday: Compass, Matterport, Toast

Compass

  • Q3 2022 earnings release after the bell; conference call at 5 p.m. ET
  • Projected loss: loss of 29 cents per share
  • Projected revenue: $1.45 billion

Matterport

  • Q3 2022 earnings release after the close; conference call at 4:30 p.m. ET
  • Projected loss: loss of 13 cents per share
  • Projected revenue: $36 million

“The era of excess allowed everyone and anything to come public, so they did,” Cramer said of Compass and Matterport.

Toast

  • Q3 2022 earnings release at 4:05 p.m. ET; conference call at 5 p.m. ET
  • Projected loss: loss of 8 cents per share
  • Projected revenue: $720 million

Toast has a good product, but a good product does not necessarily make for a good stock, Cramer said.

Disclaimer: Cramer’s Charitable Trust owns shares of Disney and Wynn Resorts.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA commissioner defends agency’s drug approval decisions after wave of backlash
Business

FDA commissioner defends agency’s drug approval decisions after wave of backlash

Martin Makary, commissioner of the Food and Drug Administration (FDA), during a news conference at the US Food and Drug Administration headquarters in Silver Spring, Maryland, US, on Tuesday, April 28, 2026. Valerie Plesch | Bloomberg | Getty Images U.S. Food and Drug Administration Commissioner Marty Makary defended himself in a CNBC interview aired Tuesday […]

Read More
Property Play: Nvidia and PulteGroup are helping this startup put mini data centers on homes
Business

Property Play: Nvidia and PulteGroup are helping this startup put mini data centers on homes

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. Even […]

Read More
Ford’s secret EV unit emerges from shadows, still bullish on new pickup amid market slowdown
Business

Ford’s secret EV unit emerges from shadows, still bullish on new pickup amid market slowdown

A Ford employee works inside a high voltage lab at Ford’s new Electric Vehicle Development Center in Long Beach, California. Courtesy Ford LONG BEACH, Calif. — As the global automotive industry retreats from all-electric vehicles after reporting billions of dollars in losses, Ford Motor continues to move forward with its next generation of EVs that […]

Read More